nodes	percent_of_prediction	percent_of_DWPC	metapath
Bexarotene—RXRB—stomach cancer	0.681	1	CbGaD
Bexarotene—CYP2C9—Capecitabine—stomach cancer	0.0117	0.415	CbGbCtD
Bexarotene—CYP2C9—Fluorouracil—stomach cancer	0.00692	0.246	CbGbCtD
Bexarotene—Tamibarotene—RARB—stomach cancer	0.00626	1	CrCbGaD
Bexarotene—CYP3A4—Irinotecan—stomach cancer	0.00419	0.149	CbGbCtD
Bexarotene—CYP3A4—Docetaxel—stomach cancer	0.00307	0.109	CbGbCtD
Bexarotene—CYP3A4—Doxorubicin—stomach cancer	0.00229	0.0814	CbGbCtD
Bexarotene—Dermatitis—Irinotecan—stomach cancer	6.76e-05	0.000402	CcSEcCtD
Bexarotene—Musculoskeletal discomfort—Docetaxel—stomach cancer	6.76e-05	0.000402	CcSEcCtD
Bexarotene—Chills—Methotrexate—stomach cancer	6.76e-05	0.000401	CcSEcCtD
Bexarotene—Headache—Irinotecan—stomach cancer	6.73e-05	0.000399	CcSEcCtD
Bexarotene—Insomnia—Docetaxel—stomach cancer	6.71e-05	0.000399	CcSEcCtD
Bexarotene—Paraesthesia—Docetaxel—stomach cancer	6.67e-05	0.000396	CcSEcCtD
Bexarotene—Alopecia—Methotrexate—stomach cancer	6.65e-05	0.000395	CcSEcCtD
Bexarotene—Dyspnoea—Docetaxel—stomach cancer	6.62e-05	0.000393	CcSEcCtD
Bexarotene—Somnolence—Docetaxel—stomach cancer	6.6e-05	0.000392	CcSEcCtD
Bexarotene—Eye disorder—Epirubicin—stomach cancer	6.59e-05	0.000391	CcSEcCtD
Bexarotene—Tinnitus—Epirubicin—stomach cancer	6.57e-05	0.00039	CcSEcCtD
Bexarotene—Erythema—Methotrexate—stomach cancer	6.56e-05	0.000389	CcSEcCtD
Bexarotene—Malnutrition—Methotrexate—stomach cancer	6.56e-05	0.000389	CcSEcCtD
Bexarotene—Haemoglobin—Doxorubicin—stomach cancer	6.55e-05	0.000389	CcSEcCtD
Bexarotene—Musculoskeletal discomfort—Capecitabine—stomach cancer	6.55e-05	0.000389	CcSEcCtD
Bexarotene—Cardiac disorder—Epirubicin—stomach cancer	6.54e-05	0.000388	CcSEcCtD
Bexarotene—Vomiting—Fluorouracil—stomach cancer	6.54e-05	0.000388	CcSEcCtD
Bexarotene—Rhinitis—Doxorubicin—stomach cancer	6.54e-05	0.000388	CcSEcCtD
Bexarotene—Dyspepsia—Docetaxel—stomach cancer	6.53e-05	0.000388	CcSEcCtD
Bexarotene—Haemorrhage—Doxorubicin—stomach cancer	6.52e-05	0.000387	CcSEcCtD
Bexarotene—Insomnia—Capecitabine—stomach cancer	6.5e-05	0.000386	CcSEcCtD
Bexarotene—Hypoaesthesia—Doxorubicin—stomach cancer	6.49e-05	0.000385	CcSEcCtD
Bexarotene—Rash—Fluorouracil—stomach cancer	6.48e-05	0.000385	CcSEcCtD
Bexarotene—Dermatitis—Fluorouracil—stomach cancer	6.48e-05	0.000385	CcSEcCtD
Bexarotene—Pharyngitis—Doxorubicin—stomach cancer	6.47e-05	0.000384	CcSEcCtD
Bexarotene—Paraesthesia—Capecitabine—stomach cancer	6.45e-05	0.000383	CcSEcCtD
Bexarotene—Decreased appetite—Docetaxel—stomach cancer	6.45e-05	0.000383	CcSEcCtD
Bexarotene—Headache—Fluorouracil—stomach cancer	6.44e-05	0.000383	CcSEcCtD
Bexarotene—Urinary tract disorder—Doxorubicin—stomach cancer	6.44e-05	0.000382	CcSEcCtD
Bexarotene—Oedema peripheral—Doxorubicin—stomach cancer	6.42e-05	0.000381	CcSEcCtD
Bexarotene—Dysgeusia—Methotrexate—stomach cancer	6.42e-05	0.000381	CcSEcCtD
Bexarotene—Gastrointestinal disorder—Docetaxel—stomach cancer	6.41e-05	0.00038	CcSEcCtD
Bexarotene—Connective tissue disorder—Doxorubicin—stomach cancer	6.41e-05	0.00038	CcSEcCtD
Bexarotene—Dyspnoea—Capecitabine—stomach cancer	6.41e-05	0.00038	CcSEcCtD
Bexarotene—Fatigue—Docetaxel—stomach cancer	6.4e-05	0.00038	CcSEcCtD
Bexarotene—Angiopathy—Epirubicin—stomach cancer	6.39e-05	0.00038	CcSEcCtD
Bexarotene—Urethral disorder—Doxorubicin—stomach cancer	6.39e-05	0.00038	CcSEcCtD
Bexarotene—Nausea—Irinotecan—stomach cancer	6.38e-05	0.000379	CcSEcCtD
Bexarotene—Pain—Docetaxel—stomach cancer	6.35e-05	0.000377	CcSEcCtD
Bexarotene—Constipation—Docetaxel—stomach cancer	6.35e-05	0.000377	CcSEcCtD
Bexarotene—Back pain—Methotrexate—stomach cancer	6.34e-05	0.000376	CcSEcCtD
Bexarotene—Dyspepsia—Capecitabine—stomach cancer	6.33e-05	0.000376	CcSEcCtD
Bexarotene—Chills—Epirubicin—stomach cancer	6.32e-05	0.000375	CcSEcCtD
Bexarotene—Arrhythmia—Epirubicin—stomach cancer	6.3e-05	0.000374	CcSEcCtD
Bexarotene—Decreased appetite—Capecitabine—stomach cancer	6.25e-05	0.000371	CcSEcCtD
Bexarotene—Alopecia—Epirubicin—stomach cancer	6.23e-05	0.00037	CcSEcCtD
Bexarotene—Gastrointestinal disorder—Capecitabine—stomach cancer	6.2e-05	0.000368	CcSEcCtD
Bexarotene—Fatigue—Capecitabine—stomach cancer	6.2e-05	0.000368	CcSEcCtD
Bexarotene—Constipation—Capecitabine—stomach cancer	6.15e-05	0.000365	CcSEcCtD
Bexarotene—Pain—Capecitabine—stomach cancer	6.15e-05	0.000365	CcSEcCtD
Bexarotene—Erythema—Epirubicin—stomach cancer	6.13e-05	0.000364	CcSEcCtD
Bexarotene—Malnutrition—Epirubicin—stomach cancer	6.13e-05	0.000364	CcSEcCtD
Bexarotene—Feeling abnormal—Docetaxel—stomach cancer	6.12e-05	0.000363	CcSEcCtD
Bexarotene—Nausea—Fluorouracil—stomach cancer	6.11e-05	0.000363	CcSEcCtD
Bexarotene—Eye disorder—Doxorubicin—stomach cancer	6.09e-05	0.000362	CcSEcCtD
Bexarotene—Ill-defined disorder—Methotrexate—stomach cancer	6.08e-05	0.000361	CcSEcCtD
Bexarotene—Tinnitus—Doxorubicin—stomach cancer	6.08e-05	0.000361	CcSEcCtD
Bexarotene—Gastrointestinal pain—Docetaxel—stomach cancer	6.07e-05	0.00036	CcSEcCtD
Bexarotene—Anaemia—Methotrexate—stomach cancer	6.06e-05	0.00036	CcSEcCtD
Bexarotene—Cardiac disorder—Doxorubicin—stomach cancer	6.05e-05	0.000359	CcSEcCtD
Bexarotene—Flatulence—Epirubicin—stomach cancer	6.04e-05	0.000359	CcSEcCtD
Bexarotene—Tension—Epirubicin—stomach cancer	6.02e-05	0.000357	CcSEcCtD
Bexarotene—Dysgeusia—Epirubicin—stomach cancer	6.01e-05	0.000357	CcSEcCtD
Bexarotene—Nervousness—Epirubicin—stomach cancer	5.96e-05	0.000354	CcSEcCtD
Bexarotene—Back pain—Epirubicin—stomach cancer	5.93e-05	0.000352	CcSEcCtD
Bexarotene—Feeling abnormal—Capecitabine—stomach cancer	5.92e-05	0.000352	CcSEcCtD
Bexarotene—Angiopathy—Doxorubicin—stomach cancer	5.92e-05	0.000351	CcSEcCtD
Bexarotene—Malaise—Methotrexate—stomach cancer	5.91e-05	0.000351	CcSEcCtD
Bexarotene—Muscle spasms—Epirubicin—stomach cancer	5.9e-05	0.00035	CcSEcCtD
Bexarotene—Vertigo—Methotrexate—stomach cancer	5.89e-05	0.00035	CcSEcCtD
Bexarotene—Gastrointestinal pain—Capecitabine—stomach cancer	5.88e-05	0.000349	CcSEcCtD
Bexarotene—Abdominal pain—Docetaxel—stomach cancer	5.87e-05	0.000348	CcSEcCtD
Bexarotene—Body temperature increased—Docetaxel—stomach cancer	5.87e-05	0.000348	CcSEcCtD
Bexarotene—Leukopenia—Methotrexate—stomach cancer	5.87e-05	0.000348	CcSEcCtD
Bexarotene—Chills—Doxorubicin—stomach cancer	5.85e-05	0.000347	CcSEcCtD
Bexarotene—Arrhythmia—Doxorubicin—stomach cancer	5.82e-05	0.000346	CcSEcCtD
Bexarotene—Alopecia—Doxorubicin—stomach cancer	5.76e-05	0.000342	CcSEcCtD
Bexarotene—Cough—Methotrexate—stomach cancer	5.72e-05	0.00034	CcSEcCtD
Bexarotene—Ill-defined disorder—Epirubicin—stomach cancer	5.69e-05	0.000338	CcSEcCtD
Bexarotene—Body temperature increased—Capecitabine—stomach cancer	5.68e-05	0.000337	CcSEcCtD
Bexarotene—Abdominal pain—Capecitabine—stomach cancer	5.68e-05	0.000337	CcSEcCtD
Bexarotene—Erythema—Doxorubicin—stomach cancer	5.68e-05	0.000337	CcSEcCtD
Bexarotene—Malnutrition—Doxorubicin—stomach cancer	5.68e-05	0.000337	CcSEcCtD
Bexarotene—Anaemia—Epirubicin—stomach cancer	5.67e-05	0.000337	CcSEcCtD
Bexarotene—Agitation—Epirubicin—stomach cancer	5.64e-05	0.000335	CcSEcCtD
Bexarotene—Flatulence—Doxorubicin—stomach cancer	5.59e-05	0.000332	CcSEcCtD
Bexarotene—Arthralgia—Methotrexate—stomach cancer	5.58e-05	0.000331	CcSEcCtD
Bexarotene—Chest pain—Methotrexate—stomach cancer	5.58e-05	0.000331	CcSEcCtD
Bexarotene—Myalgia—Methotrexate—stomach cancer	5.58e-05	0.000331	CcSEcCtD
Bexarotene—Tension—Doxorubicin—stomach cancer	5.57e-05	0.000331	CcSEcCtD
Bexarotene—Dysgeusia—Doxorubicin—stomach cancer	5.56e-05	0.00033	CcSEcCtD
Bexarotene—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—stomach cancer	5.54e-05	0.000329	CcSEcCtD
Bexarotene—Malaise—Epirubicin—stomach cancer	5.53e-05	0.000328	CcSEcCtD
Bexarotene—Discomfort—Methotrexate—stomach cancer	5.51e-05	0.000327	CcSEcCtD
Bexarotene—Nervousness—Doxorubicin—stomach cancer	5.51e-05	0.000327	CcSEcCtD
Bexarotene—Vertigo—Epirubicin—stomach cancer	5.51e-05	0.000327	CcSEcCtD
Bexarotene—Syncope—Epirubicin—stomach cancer	5.5e-05	0.000327	CcSEcCtD
Bexarotene—Leukopenia—Epirubicin—stomach cancer	5.49e-05	0.000326	CcSEcCtD
Bexarotene—Back pain—Doxorubicin—stomach cancer	5.49e-05	0.000326	CcSEcCtD
Bexarotene—Hypersensitivity—Docetaxel—stomach cancer	5.47e-05	0.000325	CcSEcCtD
Bexarotene—Muscle spasms—Doxorubicin—stomach cancer	5.46e-05	0.000324	CcSEcCtD
Bexarotene—Palpitations—Epirubicin—stomach cancer	5.42e-05	0.000322	CcSEcCtD
Bexarotene—Confusional state—Methotrexate—stomach cancer	5.39e-05	0.00032	CcSEcCtD
Bexarotene—Loss of consciousness—Epirubicin—stomach cancer	5.39e-05	0.00032	CcSEcCtD
Bexarotene—Cough—Epirubicin—stomach cancer	5.35e-05	0.000318	CcSEcCtD
Bexarotene—Asthenia—Docetaxel—stomach cancer	5.33e-05	0.000316	CcSEcCtD
Bexarotene—Infection—Methotrexate—stomach cancer	5.31e-05	0.000316	CcSEcCtD
Bexarotene—Hypertension—Epirubicin—stomach cancer	5.3e-05	0.000314	CcSEcCtD
Bexarotene—Hypersensitivity—Capecitabine—stomach cancer	5.29e-05	0.000314	CcSEcCtD
Bexarotene—Ill-defined disorder—Doxorubicin—stomach cancer	5.27e-05	0.000313	CcSEcCtD
Bexarotene—Pruritus—Docetaxel—stomach cancer	5.25e-05	0.000312	CcSEcCtD
Bexarotene—Nervous system disorder—Methotrexate—stomach cancer	5.25e-05	0.000312	CcSEcCtD
Bexarotene—Anaemia—Doxorubicin—stomach cancer	5.25e-05	0.000312	CcSEcCtD
Bexarotene—Thrombocytopenia—Methotrexate—stomach cancer	5.24e-05	0.000311	CcSEcCtD
Bexarotene—Arthralgia—Epirubicin—stomach cancer	5.22e-05	0.00031	CcSEcCtD
Bexarotene—Chest pain—Epirubicin—stomach cancer	5.22e-05	0.00031	CcSEcCtD
Bexarotene—Myalgia—Epirubicin—stomach cancer	5.22e-05	0.00031	CcSEcCtD
Bexarotene—Agitation—Doxorubicin—stomach cancer	5.22e-05	0.00031	CcSEcCtD
Bexarotene—Anxiety—Epirubicin—stomach cancer	5.2e-05	0.000309	CcSEcCtD
Bexarotene—Skin disorder—Methotrexate—stomach cancer	5.2e-05	0.000309	CcSEcCtD
Bexarotene—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—stomach cancer	5.19e-05	0.000308	CcSEcCtD
Bexarotene—Hyperhidrosis—Methotrexate—stomach cancer	5.17e-05	0.000307	CcSEcCtD
Bexarotene—Discomfort—Epirubicin—stomach cancer	5.16e-05	0.000306	CcSEcCtD
Bexarotene—Asthenia—Capecitabine—stomach cancer	5.16e-05	0.000306	CcSEcCtD
Bexarotene—Malaise—Doxorubicin—stomach cancer	5.12e-05	0.000304	CcSEcCtD
Bexarotene—Dry mouth—Epirubicin—stomach cancer	5.11e-05	0.000303	CcSEcCtD
Bexarotene—Vertigo—Doxorubicin—stomach cancer	5.1e-05	0.000303	CcSEcCtD
Bexarotene—Anorexia—Methotrexate—stomach cancer	5.1e-05	0.000303	CcSEcCtD
Bexarotene—Syncope—Doxorubicin—stomach cancer	5.09e-05	0.000302	CcSEcCtD
Bexarotene—Pruritus—Capecitabine—stomach cancer	5.08e-05	0.000302	CcSEcCtD
Bexarotene—Leukopenia—Doxorubicin—stomach cancer	5.08e-05	0.000302	CcSEcCtD
Bexarotene—Diarrhoea—Docetaxel—stomach cancer	5.08e-05	0.000302	CcSEcCtD
Bexarotene—Confusional state—Epirubicin—stomach cancer	5.05e-05	0.0003	CcSEcCtD
Bexarotene—Palpitations—Doxorubicin—stomach cancer	5.02e-05	0.000298	CcSEcCtD
Bexarotene—Oedema—Epirubicin—stomach cancer	5.01e-05	0.000297	CcSEcCtD
Bexarotene—Loss of consciousness—Doxorubicin—stomach cancer	4.99e-05	0.000296	CcSEcCtD
Bexarotene—Infection—Epirubicin—stomach cancer	4.97e-05	0.000295	CcSEcCtD
Bexarotene—Cough—Doxorubicin—stomach cancer	4.95e-05	0.000294	CcSEcCtD
Bexarotene—Shock—Epirubicin—stomach cancer	4.93e-05	0.000292	CcSEcCtD
Bexarotene—Diarrhoea—Capecitabine—stomach cancer	4.92e-05	0.000292	CcSEcCtD
Bexarotene—Nervous system disorder—Epirubicin—stomach cancer	4.91e-05	0.000292	CcSEcCtD
Bexarotene—Dizziness—Docetaxel—stomach cancer	4.91e-05	0.000291	CcSEcCtD
Bexarotene—Thrombocytopenia—Epirubicin—stomach cancer	4.9e-05	0.000291	CcSEcCtD
Bexarotene—Hypertension—Doxorubicin—stomach cancer	4.9e-05	0.000291	CcSEcCtD
Bexarotene—Tachycardia—Epirubicin—stomach cancer	4.89e-05	0.00029	CcSEcCtD
Bexarotene—Musculoskeletal discomfort—Methotrexate—stomach cancer	4.87e-05	0.000289	CcSEcCtD
Bexarotene—Skin disorder—Epirubicin—stomach cancer	4.86e-05	0.000289	CcSEcCtD
Bexarotene—Hyperhidrosis—Epirubicin—stomach cancer	4.84e-05	0.000287	CcSEcCtD
Bexarotene—Insomnia—Methotrexate—stomach cancer	4.84e-05	0.000287	CcSEcCtD
Bexarotene—Arthralgia—Doxorubicin—stomach cancer	4.83e-05	0.000287	CcSEcCtD
Bexarotene—Myalgia—Doxorubicin—stomach cancer	4.83e-05	0.000287	CcSEcCtD
Bexarotene—Chest pain—Doxorubicin—stomach cancer	4.83e-05	0.000287	CcSEcCtD
Bexarotene—Anxiety—Doxorubicin—stomach cancer	4.82e-05	0.000286	CcSEcCtD
Bexarotene—Paraesthesia—Methotrexate—stomach cancer	4.8e-05	0.000285	CcSEcCtD
Bexarotene—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—stomach cancer	4.8e-05	0.000285	CcSEcCtD
Bexarotene—Discomfort—Doxorubicin—stomach cancer	4.77e-05	0.000283	CcSEcCtD
Bexarotene—Anorexia—Epirubicin—stomach cancer	4.77e-05	0.000283	CcSEcCtD
Bexarotene—Dyspnoea—Methotrexate—stomach cancer	4.77e-05	0.000283	CcSEcCtD
Bexarotene—Somnolence—Methotrexate—stomach cancer	4.76e-05	0.000282	CcSEcCtD
Bexarotene—Dizziness—Capecitabine—stomach cancer	4.75e-05	0.000282	CcSEcCtD
Bexarotene—Dry mouth—Doxorubicin—stomach cancer	4.73e-05	0.000281	CcSEcCtD
Bexarotene—Vomiting—Docetaxel—stomach cancer	4.72e-05	0.00028	CcSEcCtD
Bexarotene—Dyspepsia—Methotrexate—stomach cancer	4.71e-05	0.00028	CcSEcCtD
Bexarotene—Rash—Docetaxel—stomach cancer	4.68e-05	0.000278	CcSEcCtD
Bexarotene—Dermatitis—Docetaxel—stomach cancer	4.68e-05	0.000278	CcSEcCtD
Bexarotene—Confusional state—Doxorubicin—stomach cancer	4.67e-05	0.000277	CcSEcCtD
Bexarotene—Decreased appetite—Methotrexate—stomach cancer	4.65e-05	0.000276	CcSEcCtD
Bexarotene—Headache—Docetaxel—stomach cancer	4.65e-05	0.000276	CcSEcCtD
Bexarotene—Oedema—Doxorubicin—stomach cancer	4.63e-05	0.000275	CcSEcCtD
Bexarotene—Gastrointestinal disorder—Methotrexate—stomach cancer	4.62e-05	0.000274	CcSEcCtD
Bexarotene—Fatigue—Methotrexate—stomach cancer	4.61e-05	0.000274	CcSEcCtD
Bexarotene—Infection—Doxorubicin—stomach cancer	4.6e-05	0.000273	CcSEcCtD
Bexarotene—Pain—Methotrexate—stomach cancer	4.57e-05	0.000272	CcSEcCtD
Bexarotene—Vomiting—Capecitabine—stomach cancer	4.57e-05	0.000271	CcSEcCtD
Bexarotene—Musculoskeletal discomfort—Epirubicin—stomach cancer	4.56e-05	0.000271	CcSEcCtD
Bexarotene—Shock—Doxorubicin—stomach cancer	4.56e-05	0.000271	CcSEcCtD
Bexarotene—Nervous system disorder—Doxorubicin—stomach cancer	4.54e-05	0.00027	CcSEcCtD
Bexarotene—Thrombocytopenia—Doxorubicin—stomach cancer	4.54e-05	0.000269	CcSEcCtD
Bexarotene—Rash—Capecitabine—stomach cancer	4.53e-05	0.000269	CcSEcCtD
Bexarotene—Insomnia—Epirubicin—stomach cancer	4.53e-05	0.000269	CcSEcCtD
Bexarotene—Dermatitis—Capecitabine—stomach cancer	4.53e-05	0.000269	CcSEcCtD
Bexarotene—Tachycardia—Doxorubicin—stomach cancer	4.52e-05	0.000268	CcSEcCtD
Bexarotene—Headache—Capecitabine—stomach cancer	4.5e-05	0.000267	CcSEcCtD
Bexarotene—Skin disorder—Doxorubicin—stomach cancer	4.5e-05	0.000267	CcSEcCtD
Bexarotene—Paraesthesia—Epirubicin—stomach cancer	4.5e-05	0.000267	CcSEcCtD
Bexarotene—Hyperhidrosis—Doxorubicin—stomach cancer	4.48e-05	0.000266	CcSEcCtD
Bexarotene—Dyspnoea—Epirubicin—stomach cancer	4.46e-05	0.000265	CcSEcCtD
Bexarotene—Somnolence—Epirubicin—stomach cancer	4.45e-05	0.000264	CcSEcCtD
Bexarotene—Anorexia—Doxorubicin—stomach cancer	4.42e-05	0.000262	CcSEcCtD
Bexarotene—Nausea—Docetaxel—stomach cancer	4.41e-05	0.000262	CcSEcCtD
Bexarotene—Feeling abnormal—Methotrexate—stomach cancer	4.41e-05	0.000262	CcSEcCtD
Bexarotene—Dyspepsia—Epirubicin—stomach cancer	4.41e-05	0.000262	CcSEcCtD
Bexarotene—Gastrointestinal pain—Methotrexate—stomach cancer	4.37e-05	0.00026	CcSEcCtD
Bexarotene—Decreased appetite—Epirubicin—stomach cancer	4.35e-05	0.000258	CcSEcCtD
Bexarotene—Gastrointestinal disorder—Epirubicin—stomach cancer	4.32e-05	0.000257	CcSEcCtD
Bexarotene—Fatigue—Epirubicin—stomach cancer	4.32e-05	0.000256	CcSEcCtD
Bexarotene—Constipation—Epirubicin—stomach cancer	4.28e-05	0.000254	CcSEcCtD
Bexarotene—Pain—Epirubicin—stomach cancer	4.28e-05	0.000254	CcSEcCtD
Bexarotene—Nausea—Capecitabine—stomach cancer	4.27e-05	0.000253	CcSEcCtD
Bexarotene—Body temperature increased—Methotrexate—stomach cancer	4.23e-05	0.000251	CcSEcCtD
Bexarotene—Abdominal pain—Methotrexate—stomach cancer	4.23e-05	0.000251	CcSEcCtD
Bexarotene—Musculoskeletal discomfort—Doxorubicin—stomach cancer	4.22e-05	0.000251	CcSEcCtD
Bexarotene—Insomnia—Doxorubicin—stomach cancer	4.19e-05	0.000249	CcSEcCtD
Bexarotene—RXRA—Gene Expression—RPL18—stomach cancer	4.17e-05	0.000358	CbGpPWpGaD
Bexarotene—RXRA—Gene Expression—RPL13—stomach cancer	4.17e-05	0.000358	CbGpPWpGaD
Bexarotene—Paraesthesia—Doxorubicin—stomach cancer	4.16e-05	0.000247	CcSEcCtD
Bexarotene—RXRA—Adipogenesis—STAT3—stomach cancer	4.15e-05	0.000356	CbGpPWpGaD
Bexarotene—Dyspnoea—Doxorubicin—stomach cancer	4.13e-05	0.000245	CcSEcCtD
Bexarotene—Feeling abnormal—Epirubicin—stomach cancer	4.13e-05	0.000245	CcSEcCtD
Bexarotene—Somnolence—Doxorubicin—stomach cancer	4.12e-05	0.000245	CcSEcCtD
Bexarotene—Gastrointestinal pain—Epirubicin—stomach cancer	4.09e-05	0.000243	CcSEcCtD
Bexarotene—Dyspepsia—Doxorubicin—stomach cancer	4.08e-05	0.000242	CcSEcCtD
Bexarotene—RXRA—Metabolism—NDUFA2—stomach cancer	4.06e-05	0.000348	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—CA1—stomach cancer	4.06e-05	0.000348	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—CKB—stomach cancer	4.06e-05	0.000348	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—FBP1—stomach cancer	4.06e-05	0.000348	CbGpPWpGaD
Bexarotene—Decreased appetite—Doxorubicin—stomach cancer	4.03e-05	0.000239	CcSEcCtD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—ERBB2—stomach cancer	4e-05	0.000343	CbGpPWpGaD
Bexarotene—Gastrointestinal disorder—Doxorubicin—stomach cancer	4e-05	0.000237	CcSEcCtD
Bexarotene—Fatigue—Doxorubicin—stomach cancer	3.99e-05	0.000237	CcSEcCtD
Bexarotene—Pain—Doxorubicin—stomach cancer	3.96e-05	0.000235	CcSEcCtD
Bexarotene—Constipation—Doxorubicin—stomach cancer	3.96e-05	0.000235	CcSEcCtD
Bexarotene—Body temperature increased—Epirubicin—stomach cancer	3.96e-05	0.000235	CcSEcCtD
Bexarotene—Abdominal pain—Epirubicin—stomach cancer	3.96e-05	0.000235	CcSEcCtD
Bexarotene—Hypersensitivity—Methotrexate—stomach cancer	3.94e-05	0.000234	CcSEcCtD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—PTGS2—stomach cancer	3.91e-05	0.000336	CbGpPWpGaD
Bexarotene—RXRA—Gene Expression—RPS15—stomach cancer	3.89e-05	0.000334	CbGpPWpGaD
Bexarotene—RXRA—Gene Expression—RPS21—stomach cancer	3.89e-05	0.000334	CbGpPWpGaD
Bexarotene—Asthenia—Methotrexate—stomach cancer	3.84e-05	0.000228	CcSEcCtD
Bexarotene—RXRA—Gene Expression—SNRPB—stomach cancer	3.83e-05	0.000329	CbGpPWpGaD
Bexarotene—Feeling abnormal—Doxorubicin—stomach cancer	3.82e-05	0.000227	CcSEcCtD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—PPAP2A—stomach cancer	3.81e-05	0.000327	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—PLIN2—stomach cancer	3.81e-05	0.000327	CbGpPWpGaD
Bexarotene—Gastrointestinal pain—Doxorubicin—stomach cancer	3.79e-05	0.000225	CcSEcCtD
Bexarotene—Pruritus—Methotrexate—stomach cancer	3.79e-05	0.000225	CcSEcCtD
Bexarotene—RXRG—Gene Expression—PPP2R1A—stomach cancer	3.76e-05	0.000323	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—CA2—stomach cancer	3.71e-05	0.000318	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—CDKN1B—stomach cancer	3.71e-05	0.000318	CbGpPWpGaD
Bexarotene—Hypersensitivity—Epirubicin—stomach cancer	3.69e-05	0.000219	CcSEcCtD
Bexarotene—Abdominal pain—Doxorubicin—stomach cancer	3.66e-05	0.000217	CcSEcCtD
Bexarotene—Body temperature increased—Doxorubicin—stomach cancer	3.66e-05	0.000217	CcSEcCtD
Bexarotene—Diarrhoea—Methotrexate—stomach cancer	3.66e-05	0.000217	CcSEcCtD
Bexarotene—RXRA—Metabolism—PGAM1—stomach cancer	3.61e-05	0.00031	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—NT5E—stomach cancer	3.61e-05	0.00031	CbGpPWpGaD
Bexarotene—RXRA—Adipogenesis—TNF—stomach cancer	3.59e-05	0.000308	CbGpPWpGaD
Bexarotene—Asthenia—Epirubicin—stomach cancer	3.59e-05	0.000213	CcSEcCtD
Bexarotene—RXRA—Generic Transcription Pathway—SMAD4—stomach cancer	3.55e-05	0.000305	CbGpPWpGaD
Bexarotene—Pruritus—Epirubicin—stomach cancer	3.54e-05	0.00021	CcSEcCtD
Bexarotene—Dizziness—Methotrexate—stomach cancer	3.54e-05	0.00021	CcSEcCtD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—CCND1—stomach cancer	3.54e-05	0.000303	CbGpPWpGaD
Bexarotene—RXRB—Gene Expression—PPP2R1A—stomach cancer	3.53e-05	0.000303	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—JUN—stomach cancer	3.53e-05	0.000303	CbGpPWpGaD
Bexarotene—RXRG—Gene Expression—SMAD4—stomach cancer	3.49e-05	0.000299	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—ALDH7A1—stomach cancer	3.45e-05	0.000296	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—PLCE1—stomach cancer	3.45e-05	0.000296	CbGpPWpGaD
Bexarotene—RXRA—Gene Expression—RORA—stomach cancer	3.44e-05	0.000295	CbGpPWpGaD
Bexarotene—Diarrhoea—Epirubicin—stomach cancer	3.43e-05	0.000203	CcSEcCtD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—CDKN1A—stomach cancer	3.42e-05	0.000293	CbGpPWpGaD
Bexarotene—Hypersensitivity—Doxorubicin—stomach cancer	3.41e-05	0.000203	CcSEcCtD
Bexarotene—Vomiting—Methotrexate—stomach cancer	3.4e-05	0.000202	CcSEcCtD
Bexarotene—Rash—Methotrexate—stomach cancer	3.37e-05	0.0002	CcSEcCtD
Bexarotene—Dermatitis—Methotrexate—stomach cancer	3.37e-05	0.0002	CcSEcCtD
Bexarotene—Headache—Methotrexate—stomach cancer	3.35e-05	0.000199	CcSEcCtD
Bexarotene—RXRA—Developmental Biology—SMAD4—stomach cancer	3.34e-05	0.000287	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—MAPK8—stomach cancer	3.34e-05	0.000286	CbGpPWpGaD
Bexarotene—Asthenia—Doxorubicin—stomach cancer	3.32e-05	0.000197	CcSEcCtD
Bexarotene—Dizziness—Epirubicin—stomach cancer	3.31e-05	0.000197	CcSEcCtD
Bexarotene—RXRA—Metabolism—UMPS—stomach cancer	3.31e-05	0.000284	CbGpPWpGaD
Bexarotene—RXRB—Gene Expression—SMAD4—stomach cancer	3.28e-05	0.000282	CbGpPWpGaD
Bexarotene—Pruritus—Doxorubicin—stomach cancer	3.28e-05	0.000195	CcSEcCtD
Bexarotene—RXRA—Gene Expression—DNMT3B—stomach cancer	3.22e-05	0.000277	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—PLIN2—stomach cancer	3.2e-05	0.000274	CbGpPWpGaD
Bexarotene—RXRG—Gene Expression—ERCC2—stomach cancer	3.19e-05	0.000273	CbGpPWpGaD
Bexarotene—Vomiting—Epirubicin—stomach cancer	3.18e-05	0.000189	CcSEcCtD
Bexarotene—Nausea—Methotrexate—stomach cancer	3.18e-05	0.000189	CcSEcCtD
Bexarotene—RXRA—Developmental Biology—FYN—stomach cancer	3.17e-05	0.000272	CbGpPWpGaD
Bexarotene—Diarrhoea—Doxorubicin—stomach cancer	3.17e-05	0.000188	CcSEcCtD
Bexarotene—RXRA—Gene Expression—RPL15—stomach cancer	3.16e-05	0.000271	CbGpPWpGaD
Bexarotene—Rash—Epirubicin—stomach cancer	3.16e-05	0.000187	CcSEcCtD
Bexarotene—Dermatitis—Epirubicin—stomach cancer	3.15e-05	0.000187	CcSEcCtD
Bexarotene—Headache—Epirubicin—stomach cancer	3.14e-05	0.000186	CcSEcCtD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—VEGFA—stomach cancer	3.08e-05	0.000264	CbGpPWpGaD
Bexarotene—RXRA—Gene Expression—RARB—stomach cancer	3.07e-05	0.000264	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—PDHA1—stomach cancer	3.07e-05	0.000264	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—ECHS1—stomach cancer	3.07e-05	0.000264	CbGpPWpGaD
Bexarotene—CYP2C9—Biological oxidations—GSTP1—stomach cancer	3.07e-05	0.000263	CbGpPWpGaD
Bexarotene—Dizziness—Doxorubicin—stomach cancer	3.06e-05	0.000182	CcSEcCtD
Bexarotene—CYP2C9—Metapathway biotransformation—GSTP1—stomach cancer	3.02e-05	0.00026	CbGpPWpGaD
Bexarotene—RXRB—Gene Expression—ERCC2—stomach cancer	2.99e-05	0.000257	CbGpPWpGaD
Bexarotene—Nausea—Epirubicin—stomach cancer	2.97e-05	0.000177	CcSEcCtD
Bexarotene—RXRA—Transmembrane transport of small molecules—HMOX1—stomach cancer	2.96e-05	0.000254	CbGpPWpGaD
Bexarotene—RXRA—Gene Expression—RPS26—stomach cancer	2.95e-05	0.000253	CbGpPWpGaD
Bexarotene—Vomiting—Doxorubicin—stomach cancer	2.95e-05	0.000175	CcSEcCtD
Bexarotene—Rash—Doxorubicin—stomach cancer	2.92e-05	0.000173	CcSEcCtD
Bexarotene—Dermatitis—Doxorubicin—stomach cancer	2.92e-05	0.000173	CcSEcCtD
Bexarotene—CYP3A4—Biological oxidations—GSTT1—stomach cancer	2.92e-05	0.00025	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—MAPK3—stomach cancer	2.92e-05	0.00025	CbGpPWpGaD
Bexarotene—Headache—Doxorubicin—stomach cancer	2.9e-05	0.000172	CcSEcCtD
Bexarotene—RXRA—Adipogenesis—IL6—stomach cancer	2.9e-05	0.000249	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—FADS1—stomach cancer	2.89e-05	0.000248	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—TYMP—stomach cancer	2.89e-05	0.000248	CbGpPWpGaD
Bexarotene—CYP3A4—Biological oxidations—CYP2A6—stomach cancer	2.88e-05	0.000247	CbGpPWpGaD
Bexarotene—RXRG—Generic Transcription Pathway—MYC—stomach cancer	2.88e-05	0.000247	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—MYC—stomach cancer	2.84e-05	0.000243	CbGpPWpGaD
Bexarotene—CYP2C9—Biological oxidations—GSTM1—stomach cancer	2.82e-05	0.000242	CbGpPWpGaD
Bexarotene—CYP2C9—Metapathway biotransformation—GSTM1—stomach cancer	2.78e-05	0.000238	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—MAPK1—stomach cancer	2.77e-05	0.000238	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—EGFR—stomach cancer	2.77e-05	0.000238	CbGpPWpGaD
Bexarotene—CYP3A4—Metapathway biotransformation—AKR1C3—stomach cancer	2.77e-05	0.000237	CbGpPWpGaD
Bexarotene—Nausea—Doxorubicin—stomach cancer	2.75e-05	0.000163	CcSEcCtD
Bexarotene—RXRA—Metabolism—SREBF2—stomach cancer	2.71e-05	0.000232	CbGpPWpGaD
Bexarotene—RXRB—Generic Transcription Pathway—MYC—stomach cancer	2.7e-05	0.000232	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—RORA—stomach cancer	2.67e-05	0.000229	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—TNF—stomach cancer	2.64e-05	0.000227	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—ACAD8—stomach cancer	2.64e-05	0.000226	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—KRAS—stomach cancer	2.62e-05	0.000225	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—ECHS1—stomach cancer	2.58e-05	0.000221	CbGpPWpGaD
Bexarotene—RXRA—Gene Expression—HSPB1—stomach cancer	2.58e-05	0.000221	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—CDK4—stomach cancer	2.56e-05	0.00022	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—MET—stomach cancer	2.56e-05	0.00022	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—IL6ST—stomach cancer	2.51e-05	0.000215	CbGpPWpGaD
Bexarotene—RXRA—Gene Expression—RPS19—stomach cancer	2.51e-05	0.000215	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—ALDOB—stomach cancer	2.51e-05	0.000215	CbGpPWpGaD
Bexarotene—RXRA—Generic Transcription Pathway—PPARG—stomach cancer	2.47e-05	0.000212	CbGpPWpGaD
Bexarotene—RXRG—Gene Expression—PPARG—stomach cancer	2.43e-05	0.000208	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—FADS1—stomach cancer	2.42e-05	0.000208	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—PIK3CA—stomach cancer	2.41e-05	0.000207	CbGpPWpGaD
Bexarotene—RXRA—Gene Expression—DNMT1—stomach cancer	2.39e-05	0.000206	CbGpPWpGaD
Bexarotene—RXRA—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	2.36e-05	0.000203	CbGpPWpGaD
Bexarotene—RXRA—Gene Expression—HSPA8—stomach cancer	2.36e-05	0.000203	CbGpPWpGaD
Bexarotene—RXRA—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	2.36e-05	0.000202	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—GMPR2—stomach cancer	2.35e-05	0.000202	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—ALOX5—stomach cancer	2.33e-05	0.0002	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—TP53—stomach cancer	2.33e-05	0.0002	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—PPARG—stomach cancer	2.33e-05	0.0002	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—DPYD—stomach cancer	2.29e-05	0.000197	CbGpPWpGaD
Bexarotene—RXRB—Gene Expression—PPARG—stomach cancer	2.28e-05	0.000196	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—SREBF2—stomach cancer	2.27e-05	0.000195	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—RORA—stomach cancer	2.24e-05	0.000192	CbGpPWpGaD
Bexarotene—RXRA—Transmembrane transport of small molecules—APOA1—stomach cancer	2.24e-05	0.000192	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—IL6R—stomach cancer	2.24e-05	0.000192	CbGpPWpGaD
Bexarotene—RXRA—Generic Transcription Pathway—SERPINE1—stomach cancer	2.23e-05	0.000191	CbGpPWpGaD
Bexarotene—RXRA—Gene Expression—RPS6—stomach cancer	2.22e-05	0.00019	CbGpPWpGaD
Bexarotene—RXRG—Gene Expression—SERPINE1—stomach cancer	2.19e-05	0.000188	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—SUCLG1—stomach cancer	2.15e-05	0.000184	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—IDH3B—stomach cancer	2.15e-05	0.000184	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—MMP2—stomach cancer	2.14e-05	0.000183	CbGpPWpGaD
Bexarotene—RXRA—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	2.08e-05	0.000178	CbGpPWpGaD
Bexarotene—RXRB—Gene Expression—SERPINE1—stomach cancer	2.06e-05	0.000176	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—GSTT1—stomach cancer	2.03e-05	0.000174	CbGpPWpGaD
Bexarotene—CYP3A4—Biological oxidations—GSTP1—stomach cancer	2.02e-05	0.000174	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—RHOA—stomach cancer	2.02e-05	0.000173	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—CYP2A6—stomach cancer	2e-05	0.000172	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—NDUFV1—stomach cancer	2e-05	0.000171	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—NDUFS1—stomach cancer	2e-05	0.000171	CbGpPWpGaD
Bexarotene—CYP3A4—Metapathway biotransformation—GSTP1—stomach cancer	1.99e-05	0.000171	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—ALOX5—stomach cancer	1.95e-05	0.000168	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—AKR1C3—stomach cancer	1.95e-05	0.000167	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—ENO1—stomach cancer	1.9e-05	0.000163	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—ERBB2—stomach cancer	1.87e-05	0.000161	CbGpPWpGaD
Bexarotene—RXRA—Metabolism of lipids and lipoproteins—ALB—stomach cancer	1.87e-05	0.00016	CbGpPWpGaD
Bexarotene—CYP3A4—Biological oxidations—GSTM1—stomach cancer	1.86e-05	0.000159	CbGpPWpGaD
Bexarotene—RXRA—Gene Expression—PPP2R1A—stomach cancer	1.84e-05	0.000158	CbGpPWpGaD
Bexarotene—CYP3A4—Metapathway biotransformation—GSTM1—stomach cancer	1.83e-05	0.000157	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—BLVRB—stomach cancer	1.78e-05	0.000153	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—PGLS—stomach cancer	1.78e-05	0.000153	CbGpPWpGaD
Bexarotene—RXRA—Transmembrane transport of small molecules—ALB—stomach cancer	1.78e-05	0.000152	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—ACAD8—stomach cancer	1.74e-05	0.000149	CbGpPWpGaD
Bexarotene—RXRA—Gene Expression—SMAD4—stomach cancer	1.71e-05	0.000147	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—PPAP2A—stomach cancer	1.7e-05	0.000146	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—CD44—stomach cancer	1.68e-05	0.000145	CbGpPWpGaD
Bexarotene—RXRA—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	1.63e-05	0.00014	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C3—stomach cancer	1.63e-05	0.00014	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—MMP9—stomach cancer	1.61e-05	0.000138	CbGpPWpGaD
Bexarotene—RXRA—Gene Expression—ERCC2—stomach cancer	1.56e-05	0.000134	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—GMPR2—stomach cancer	1.55e-05	0.000133	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—FBP1—stomach cancer	1.51e-05	0.00013	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—CA1—stomach cancer	1.51e-05	0.00013	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—NDUFA2—stomach cancer	1.51e-05	0.00013	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—CKB—stomach cancer	1.51e-05	0.00013	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—VEGFA—stomach cancer	1.44e-05	0.000124	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—PPP2R1A—stomach cancer	1.43e-05	0.000123	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—STAT3—stomach cancer	1.43e-05	0.000122	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—PLIN2—stomach cancer	1.42e-05	0.000122	CbGpPWpGaD
Bexarotene—RXRG—Gene Expression—MAPK3—stomach cancer	1.42e-05	0.000122	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—IDH3B—stomach cancer	1.42e-05	0.000122	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—SUCLG1—stomach cancer	1.42e-05	0.000122	CbGpPWpGaD
Bexarotene—RXRA—Generic Transcription Pathway—MYC—stomach cancer	1.41e-05	0.000121	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—GSTP1—stomach cancer	1.4e-05	0.000121	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—HMOX1—stomach cancer	1.39e-05	0.000119	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—CA2—stomach cancer	1.38e-05	0.000119	CbGpPWpGaD
Bexarotene—RXRG—Gene Expression—MYC—stomach cancer	1.38e-05	0.000119	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—MAPK3—stomach cancer	1.36e-05	0.000117	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—NT5E—stomach cancer	1.35e-05	0.000116	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—PGAM1—stomach cancer	1.35e-05	0.000116	CbGpPWpGaD
Bexarotene—RXRB—Gene Expression—MAPK3—stomach cancer	1.34e-05	0.000115	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—NDUFS1—stomach cancer	1.32e-05	0.000113	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—NDUFV1—stomach cancer	1.32e-05	0.000113	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—TYMS—stomach cancer	1.31e-05	0.000112	CbGpPWpGaD
Bexarotene—RXRB—Gene Expression—MYC—stomach cancer	1.3e-05	0.000112	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—MAPK1—stomach cancer	1.3e-05	0.000111	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—EGFR—stomach cancer	1.3e-05	0.000111	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—GSTM1—stomach cancer	1.29e-05	0.000111	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—PLCE1—stomach cancer	1.29e-05	0.00011	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—ALDH7A1—stomach cancer	1.29e-05	0.00011	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—TNF—stomach cancer	1.24e-05	0.000106	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—UMPS—stomach cancer	1.23e-05	0.000106	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—KRAS—stomach cancer	1.23e-05	0.000105	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—ERCC2—stomach cancer	1.21e-05	0.000104	CbGpPWpGaD
Bexarotene—RXRA—Gene Expression—PPARG—stomach cancer	1.19e-05	0.000102	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—BLVRB—stomach cancer	1.17e-05	0.000101	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—PGLS—stomach cancer	1.17e-05	0.000101	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—PDHA1—stomach cancer	1.15e-05	9.85e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—ECHS1—stomach cancer	1.15e-05	9.85e-05	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—MTHFR—stomach cancer	1.14e-05	9.79e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—PPAP2A—stomach cancer	1.12e-05	9.61e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—FADS1—stomach cancer	1.08e-05	9.26e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—TYMP—stomach cancer	1.08e-05	9.26e-05	CbGpPWpGaD
Bexarotene—RXRA—Gene Expression—SERPINE1—stomach cancer	1.07e-05	9.2e-05	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—CAV1—stomach cancer	1.05e-05	9.03e-05	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—APOA1—stomach cancer	1.05e-05	9.01e-05	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—HRAS—stomach cancer	1.04e-05	8.94e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—SREBF2—stomach cancer	1.01e-05	8.67e-05	CbGpPWpGaD
Bexarotene—RXRA—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	1.01e-05	8.63e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—FBP1—stomach cancer	9.99e-06	8.57e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—NDUFA2—stomach cancer	9.99e-06	8.57e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—CKB—stomach cancer	9.99e-06	8.57e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—CA1—stomach cancer	9.99e-06	8.57e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—RORA—stomach cancer	9.98e-06	8.57e-05	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—IL6—stomach cancer	9.97e-06	8.55e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—PLIN2—stomach cancer	9.39e-06	8.06e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—ALDOB—stomach cancer	9.35e-06	8.03e-05	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—PPARG—stomach cancer	9.25e-06	7.94e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—CA2—stomach cancer	9.13e-06	7.84e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—PGAM1—stomach cancer	8.9e-06	7.64e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—NT5E—stomach cancer	8.9e-06	7.64e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	8.82e-06	7.57e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	8.8e-06	7.55e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—ALOX5—stomach cancer	8.7e-06	7.46e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—DPYD—stomach cancer	8.56e-06	7.34e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—PLCE1—stomach cancer	8.49e-06	7.29e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—ALDH7A1—stomach cancer	8.49e-06	7.29e-05	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—ALB—stomach cancer	8.32e-06	7.14e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—UMPS—stomach cancer	8.14e-06	6.99e-05	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—NOS3—stomach cancer	7.96e-06	6.83e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	7.75e-06	6.65e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—PDHA1—stomach cancer	7.57e-06	6.49e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—ECHS1—stomach cancer	7.57e-06	6.49e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—GSTT1—stomach cancer	7.57e-06	6.49e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—CYP2A6—stomach cancer	7.48e-06	6.42e-05	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—PTGS2—stomach cancer	7.28e-06	6.24e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—AKR1C3—stomach cancer	7.27e-06	6.24e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—TYMP—stomach cancer	7.12e-06	6.11e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—FADS1—stomach cancer	7.12e-06	6.11e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—ENO1—stomach cancer	7.09e-06	6.08e-05	CbGpPWpGaD
Bexarotene—RXRA—Gene Expression—MAPK3—stomach cancer	6.97e-06	5.98e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—ALB—stomach cancer	6.97e-06	5.98e-05	CbGpPWpGaD
Bexarotene—RXRA—Gene Expression—MYC—stomach cancer	6.78e-06	5.82e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—SREBF2—stomach cancer	6.66e-06	5.72e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—RORA—stomach cancer	6.58e-06	5.65e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—CD44—stomach cancer	6.29e-06	5.4e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—ALDOB—stomach cancer	6.17e-06	5.29e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	6.1e-06	5.23e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—ALOX5—stomach cancer	5.74e-06	4.92e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—DPYD—stomach cancer	5.64e-06	4.84e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—PPP2R1A—stomach cancer	5.35e-06	4.59e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—GSTP1—stomach cancer	5.24e-06	4.5e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—HMOX1—stomach cancer	5.17e-06	4.44e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—GSTT1—stomach cancer	4.99e-06	4.28e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—CYP2A6—stomach cancer	4.93e-06	4.23e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—TYMS—stomach cancer	4.88e-06	4.18e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—GSTM1—stomach cancer	4.82e-06	4.14e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—AKR1C3—stomach cancer	4.8e-06	4.12e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—ENO1—stomach cancer	4.68e-06	4.01e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—ERCC2—stomach cancer	4.53e-06	3.89e-05	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—PIK3CA—stomach cancer	4.48e-06	3.84e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—MTHFR—stomach cancer	4.26e-06	3.65e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—CD44—stomach cancer	4.15e-06	3.56e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—CAV1—stomach cancer	3.93e-06	3.37e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—APOA1—stomach cancer	3.92e-06	3.36e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	3.75e-06	3.22e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—PPP2R1A—stomach cancer	3.53e-06	3.03e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—GSTP1—stomach cancer	3.46e-06	2.97e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—PPARG—stomach cancer	3.45e-06	2.96e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—HMOX1—stomach cancer	3.41e-06	2.93e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—TYMS—stomach cancer	3.22e-06	2.76e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—GSTM1—stomach cancer	3.18e-06	2.73e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—ALB—stomach cancer	3.11e-06	2.66e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—ERCC2—stomach cancer	2.99e-06	2.56e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—NOS3—stomach cancer	2.97e-06	2.55e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—MTHFR—stomach cancer	2.81e-06	2.41e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—PTGS2—stomach cancer	2.72e-06	2.33e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—CAV1—stomach cancer	2.59e-06	2.22e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—APOA1—stomach cancer	2.58e-06	2.22e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—PPARG—stomach cancer	2.28e-06	1.95e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—ALB—stomach cancer	2.05e-06	1.76e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—NOS3—stomach cancer	1.96e-06	1.68e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—PTGS2—stomach cancer	1.79e-06	1.54e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—PIK3CA—stomach cancer	1.67e-06	1.43e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—PIK3CA—stomach cancer	1.1e-06	9.46e-06	CbGpPWpGaD
